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Abstract 
Mycoplasma hominis is a member of the genus mycoplasma and has only been isolated from hu-
mans. It is most frequently isolated from the urogenital tract in the absence of symptoms, but has 
been isolated from wounds, brain abscess, inflamed joints, blood and placenta from pregnancy 
with adverse outcomes (especially preterm birth and occasionally term stillbirth). Controversy 
surrounds whether this organism is a commensal or a pathogen; however, Mycoplasma hominis 
has been shown to induce preterm birth and foetal lung injury in an experimental primate model 
as a sole pathogen. These bacteria are known to exist as a parasitic infection, due to a number of 
missing synthetic and metabolism pathway enzymes from their minimal genome; therefore, the 
ability to adhere to host cells is important. Here we provide a review that clarifies the different 
nomenclature (variable adherence-associated antigen and P50) that has been used to investigate 
the major surface adhesin for this organism, as well as reported mechanisms responsible for 
turning off its expression. Variation in the structure of this protein can be used to separate strains 
into six categories, a method that we were able to use to distinguish and characterise 12 UK 
strains isolated from between 1983 and 2012. We propose that the Vaa should be used in further 
investigations to determine if commensal populations and those that are associated with disease 
utilise different forms of this adhesin, as this is under-studied and identification of pathogenic de-
terminants is overdue for this organism. 
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1. Introduction 
Mycoplasmas are characterised by vastly reduced genomes and are among the smallest of the free-living organ-
isms. Furthermore, mycoplasmas are diverse in terms of host environment, phenotypic features, as well as ge-
nomic characteristics [1]. They feature a reduced number of DNA repair proteins and exhibit high mutation rates, 
which contributes to the accelerated evolution observed within the genus [2]. 
Most mycoplasmas are parasites, usually exhibiting strict host and tissue specificities. These organisms have 
evolved molecular mechanisms needed to deal with the host immune response including: mimicry of host anti-
gens, survival within phagocytic and non-phagocytic cells and generation of phenotype plasticity. Mycoplasma 
hominis is an opportunistic human pathogen and resides as a commensal on the mucosal surfaces of the cervix 
or vagina of 21% to 53% of sexually mature, asymptomatic women; this is somewhat lower in the urethra of 
males [3]. However, M. hominis has also been associated with clinically diverse diseases including; urogenital 
diseases [4] [5], postpartum fever [6], pneumonia [7], meningitis [8] [9] and septic arthritis [10] [11]. Although 
this organism has only been isolated from humans, it was found that in utero administration of M. hominis to 
pregnant macaque monkeys led to preterm labour and foetal lung injury [12]. 
Mutation-based phenotypic and genetic variation is a strategy utilised by many pathogenic bacteria and pro-
tozoa to adapt to divergent host environments [13] [14]. These mutations often affect the surface structures of a 
pathogen and may therefore change functional aspects of the organism such as adherence, colonisation of the 
host, or immune evasion. High-frequency mutations, that are distinct from classical regulation of gene expres-
sion, are an adaptive tactic that can affect the expression or structure of selected gene products, creating and 
maintaining repertoires of functionally variant organisms within a population. This diversity may contribute in 
many ways to the survival, propagation, transmission and pathogenic properties of an infectious agent.  
Mycoplasmas are heterogeneous organisms: many display antigenic variation and pronounced variation of 
surface proteins. This is thought to be an important way of evading the host immune response, particularly the 
humoral immune response, resulting in the chronic infection characteristic of many mycoplasma infections [15]. 
Previous studies have indicated that the surface antigenic profiles of M. hominis strains are highly heterogeneous 
expressing both size and phase variants of surface exposed membrane proteins [16]-[19]. Several M. hominis 
surface proteins have been characterised including P120, P135 and P50, however the molecular basis of varia-
tion in M. hominis has only been elucidated in some cases. The mechanisms involved in the diversification of 
mycoplasma surface proteins are highly complex and include: size variation caused by gain or loss of intragenic 
repetitive sequences; phase switching by deletion/insertion mutations or DNA inversion affecting promoter ac-
tivity; and presence of multigene families or multiple copies of partial genes in the mycoplasmal chromosome 
[1].  
The presence of a variable adherence-associated surface protein of M. hominis was initially identified over 20 
years ago as a potential adhesin of M. hominis by using specific monoclonal antibodies to inhibit mycoplasma 
adherence to cultured cells [17] [20]. This protein was first identified; as a 49 kDa surface protein in M. hominis 
strain PG21 [21]; as an adherence-associated, multiple-banding membrane lipoprotein in strain 1620 [17]; and as 
a 50 kDa adhesin in strain FBG, known as P50 [20]. While these groups used different nomenclature (Vaa versus 
P50), the surface lipoprotein in question is the same protein. We will use the original terminology, variable ad-
herence-associated (Vaa) antigen, for the rest of this review as this lipoprotein often has varying molecular 
masses with conserved regions; therefore P50 is a less accurate descriptor. Variation in the composition and size 
of the Vaa proteins results from allelic variant forms of the single copy vaa gene in M. hominis [22] [23]. De-
spite discovery for more than two decades no comprehensive review of Vaa regulation and expression has been 
previously undertaken, the importance of Vaa in the pathogenesis and immune evasion of M. hominis infections 
is still not fully elucidated. 
2. Phase Variation of the vaa Gene 
Tandem repeats (TRs) are nucleotide sequences that are directly repeated in a head-to-tail manner. According to 
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the conservation of the repeated sequences, TRs are classified as identical/perfect TRs or degenerated/imperfect 
TRs. Furthermore, TRs can be classified into three categories according to the size of the repeated unit: mi-
crosatellites, minisatellites and macrosatellites [24] [25]. The term “satellite DNA” originally refers to the very 
large arrays of tandemly repeated non-coding DNA that are characteristic of eukaryotic genomes however in the 
context of bacterial genomes the term is also used to include small and intragenic TRs [26]. In comparison to 
other bacterial species, several mycoplasma species, including M. genitalium, M. gallisepticum, and M. 
hyopneumoniae, contain long trinucleotide repeats in their genomes at a higher prevalence than is observed in 
other bacterial species. These repeat regions occur mainly in intragenic regions in the two former species and 
within coding regions of the latter [27]. In M. hyopneumoniae the trinucleotide repeats are located within hypo-
thetical open reading frames or defined adhesins in which the gain or loss of these repeats results in variability 
of amino acid sequence. These changes in protein size and structure are speculated to influence protein-protein 
interactions and adhesion [27]. 
There is abundant evidence that intragenic and intergenic TRs can promote phase variation. However, the un-
derlying mechanisms are dependent on the nature of the TR. For example, if the TR unit size is not a multiple of 
three, rearrangements are able to induce frame-shift mutations causing ON/OFF phase variation of down-stream 
sequence (truncation) [26]. Phase variation refers to reversible molecular switches encoding ON/OFF gene ex-
pression resulting in variation in expression of one or more open-reading frames between individual cells of a 
clonal population. The frequency of phase variation is characteristic for the gene, the bacterial species, and the 
regulatory mechanism resulting in modulation of the switching frequency. Phase variation results in phenotypic 
variation within bacterial species [28]. Differences in the expression of Vaa between strains of M. hominis have 
been observed and Vaa has been shown to undergo high-frequency phase variation resulting in ON/OFF expres-
sion [17] [22]. Sequence differences have been observed between Vaa positive (Vaa+) and Vaa negative (Vaa−) 
variants derived from a single clonal lineage, with a single nucleotide deletion observed in a short tract of ade-
nine residues (poly-A tract) located 166 nucleotides downstream of the ATG start codon. This tract contains 
eight alanine residues in cells expressing the full-length Vaa protein [23]. The deletion observed in Vaa− variants 
creates a frame-shift resulting in an in-frame UAG stop codon downstream of the poly-A tract.This mutation 
causes premature termination of translation and prevents Vaa expression [22]. Correction of this mutation has 
been observed in Vaa+ variants derived from a Vaa− clonal population, restoring the eight A residues in the poly- 
A tract, and resulting in the expression of the full-length Vaa [22]. Thus phase variation of Vaa is controlled at 
translation, not as a consequence of transcriptional events due to promoter sequence divergence unlike transcrip-
tional modulation of frame-shift mutations seen in other bacteria such as Necesseria gonorrhoeae and Urea-
plasma sp. [22] [29]-[31].  
3. Size and Antigenic Variation of vaa 
Size variation has been observed in Vaa using the monoclonal antibody H3 that was used to initially identify this 
protein, can inhibit the growth of M. hominis, and blocks attachment to host cells [17]. The size of Vaa observed 
in different isolates ranged from 28 kDa to 72 kDa and resulted from the gain or loss of intragenic repetitive se-
quences. Size variation of Vaa was initially examined in clonal lineages generated from M. hominis strain 1620, 
wherein three size variants of the Vaa antigen were identified and designated Vaa-2, Vaa-3, and Vaa-4. Sequence 
analysis showed that this vaa gene length variation corresponded to the number of 363 bp intragenic TR ele-
ments and the number of repeats was then used in the nomenclature of the different clonal lineages: Vaa-2 (two 
repeats), Vaa-3 (three repeats), and Vaa-4 (four repeats) [23]. These repeats form the basis of “modules” which 
provide a platform for further separation of Vaa types into categories (Figure 1). This 363 bp repeat became the 
prototype for what is now referred to as module III. 
As shown in Figure 1, the first 240 amino acids of the FBG (P50) and 1620 Vaa proteins are highly homolo-
gous (96% amino acid identity), both of which contain a module III, however, divergence of the downstream 
sequence required the classification of further modules [32]. Sequence homology for each module type was ini-
tially restricted to 82% between strains [23] [32]. All vaa genes described thus far all start with highly homolo-
gous modules I and II, followed by either module II’ or II’’. All reported combinations of identified module 
types analysed in over 100 clinical isolates [32] [33] has resulted in six possible categories (Figure 1); however, 
the number of module III in category 4 have been found to vary between two and four repeats.  
Module I contains 27 amino acids that encode the putative prolipoprotein signal peptide of the precursor pro-
tein [34]. This signal peptide is cleaved off in the mature Vaa, and the resulting N-terminal cysteine is lipid-  
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Figure 1. Schematic representation of the deduced amino acid sequences of the six vaa gene types. The proteins show 
a modular composition with homologous modules showing more than 82% amino acid identity. Modules I, II and I’/II” 
form the conserved N-terminal of the protein and Module VI represents the 10 amino acids conserved at the C-terminal. 
Modules III, IV, V, VII and VIII form the interchangeable cassettes. Prototype M. hominis strains for each Vaa cate-
gory are stated along with corresponding strains from Henrich et al. (1998) [33]. Figure modified from Boesen et al. 
(1998) [32].                                                                                         
 
modified, allowing the protein to be anchored to the bacterial membrane [35]. Module II encodes the conserved 
N-terminal end of the mature protein. Due to low sequence homology in the C-terminal end of this module, the 
amino acid region 105 - 118 has been split into two further modules, module II’ and module II’’. Module VI en-
codes the conserved 10 amino acids at C-terminal of all reported Vaa proteins. 
Modules III, IV, V, VII and VIII form an interchangeable set of sequences that provide the size variation ob-
served in Vaa variants. Inter-module homology (38% - 78%) suggests a common ancestral sequence [32]. A sta-
ble, repeated motif of four amino acids (SFKE) was observed in module II, a constant part of the gene. This mo-
tif was extended to ELESFKE in almost all of the interchangeable cassettes (identified by arrowed regions in 
Figure 2 and Figure 3). Three highly conserved tryptophan residues were also identified in distinct positions in 
a 16 amino acid region situated in the C-terminal part of the cassette sequence (identified by triangles in Figure 
2 and Figure 3) [32].  
Using the previously proposed method of characterising Vaa type based on module composition as in Figure 
1, we analysed 12 UK M. hominis strains that were collected between 1983 and 2012. The entire vaa gene was 
sequenced and the amino acid composition predicted from the open-reading frame (methods given in supple-
mentary appendix). Eight of the UK strains belonged to category 1 and the remaining 4 were determined to be-
long to category 2 (alignments shown in Figure 2 and Figure 3). Aligning UK and prototype strains for cate-
gory 1 Vaa showed a very high homology for modules I, II, and II”. The UK2012c strain had five unique poly-
morphisms through this region compared to the other strains, and it is interesting to note that this colony-  
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purified strain originated from the same patient sample as UK2012b. This suggests that while Vaa type may be 
conserved within isolates from the same sample, micro-polymorphisms can exist within the same isolate. Of 
further note, nucleotide homology between these two strains for ten other essential genes showed 100% identity 
(data not shown), suggesting that Vaa may be more prone to mutation. In all strains analysed, the SFKE and 
ELESFKE motifs were conserved in module II and in the interchangeable cassettes, respectively. The conserved 
tryptophan residues can also be observed in the interchangeable cassettes. In the strains analysed, the modules 
that contain the highest levels of variation occur at the C-terminal end of the interchangeable cassette region, 
module V and module VII in Vaa category 1 and Vaa category 2, respectively. In fact, module V fails to maintain 
the 82% homology between isolates suggested by Boesen et al. (1998) to be required for inclusion in a particular 
module [32]. C-terminal modules appear to be hyper-variable in comparison to the other modules of the protein, 
indicating that there may be higher selective pressure to vary this region of the protein, suggesting that the 
C-terminus of Vaa may be more important to immune surveillance than more membrane-proximal modules. An- 
 
 
Figure 2. Alignment of the deduced amino acid sequence of Vaa category 1. Amino acid sequences of eight UK M. 
hominis strains and two prototype M. hominis strains (FBG and PG21) are shown. The modular composition of the 
protein is indicated and polymorphisms are highlighted by a blue box. The conserved SFKE and ELESFKE motifs 
(arrowed region) are observed in all proteins. Three tryptophan residues (triangle) are also conserved in the inter-
changeable cassette sequences.                                                                           
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Figure 3. Alignment of the deduced amino acid sequence of Vaa category 2. Amino acid sequences of 
four UK M. hominis strains and a prototype M. hominis strain (132) are shown. The modular composi-
tion of the protein is indicated and polymorphisms are highlighted by a blue box. The conserved SFKE 
and ELESFKE motifs (arrowed region) are observed in all proteins. Three tryptophan residues (triangle) 
are also conserved in the interchangeable cassette sequences.                                       
 
tigenic variation is important to the expression of functionally conserved moieties within a clonal population that 
are antigenically distinct [28].  
The presence of these highly homologous interchangeable cassettes in the vaa gene suggests a mechanism of 
variation in which homologous recombination provides insertions or deletions of whole cassettes. This is most 
obvious in the Vaa-2, Vaa-3, and Vaa-4 variants isolated from a common ancestor (strain 1620). Homologous 
recombination can bring mutations arising in different genomes together and has a strong impact on pathogenic 
adaptation [36]. Homologous recombination was found in the penicillin-binding-proteins (PBPs) of Streptococ-
cus pneumoniae, N. gonorrhoeae and N. meningitides and resulted in a mosaic gene structure [37]-[39]. Se-
quence blocks in the class A genes of resistant strains of S. pneumoniae confer decreased affinity to penicillin 
however these sequence blocks also contain mosaics of sequence similar to the sensitive strains. These blocks 
were thought to arise by interspecies horizontal genetic transfers followed by homologous recombination [40]. 
The class I outer membrane protein of N. meningitidis displays evidence of homologous recombination follow-
R. J. Brown et al. 
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ing intraspecies horizontal gene transfer resulting in the exchange of variable domains giving rise to antigenic 
variation of this protein [41]. The absence of sequences homologous to the vaa gene in other members of the 
mycoplasma family or other bacterial species suggests that intraspecies genetic transfer is responsible for the 
current array of Vaa categories. 
4. Secondary and Tertiary Structure of Vaa 
Sequence analysis and modelling of the Vaa protein indicates that Vaa belongs to the group of monomeric mi-
crobial surface-exposed coiled-coil proteins similar to Protein A of Staphylococci [35] [42] [43]. Vaa axial shape 
ratios indicate that the C-terminal region of the protein is elongated whereas the N-terminal region is globular. 
The secondary structure of Vaa examined by circular dichroism spectra and Jpred2 analysis indicated a primarily 
α helical structure with a predicted N-terminal region containing three α-helices interrupted by short breaks in 
helicity. Jpred2 analysis of the cassette region of the protein predicted two α-helices followed by two β-sheets 
and an α-helix. The secondary structure prediction of the C-terminal region of the protein implies the presence 
of two α-helices separated by a β-sheet [35].  
A hypothetical model, Figure 4, of the topology of Vaa shows a bacterial membrane lipid anchor that is typi-
cal of prokaryotic lipoproteins attached to the N-terminal cysteine residue of the mature Vaa with the conserved 
N-terminal in a triple-helix bundle, extending into an elongated helix. Two β sheets then form a loop region and 
a C-terminal helix folds back on the elongated helix. This model indicates that Vaa is composed of an N-termi- 
nal base domain in close proximity to the membrane and a C-terminal spike cassette domain projecting out from 
the surface of M. hominis [35]. The Vaa protein is characterised by its modular structure with different numbers 
 
 
Figure 4. Model of the predicted protein structure for Vaa category 5. (A) Schematic rep-
resentation of Vaa category 5 modified from Boesen et al. (2001) [35]. The modules are 
numbered as outlined in Figure 1. (B) Protein homology model of Vaa category 5 strain 
2867B. Model was created using www.swissmodel.expasy.org and uses NheA protein as a 
template. (C) Alignment of Vaa category 5 strain 2867B amino acid sequence with the 
NheA protein template. Secondary structure is indicated in the template.                    
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of interchangeable cassette sequences. It was originally proposed that the addition of a cassette could create a 
more elongated protein. However, analysis of a Vaa category 3 protein and a Vaa category 5 protein has revealed 
that the axial shape ratios of these two proteins, determined by circular dichroism, are almost identical, indicat-
ing that the interchangeable cassettes were arranged in parallel and not end-to-end [23] [35]. 
5. Role of Vaa in Cyto-Adherence 
Mycoplasmas have small genomes and limited biosynthetic capabilities, restricting them to a parasitic existence 
in association with eukaryotic cells of their host [3] [44]. The ability of mycoplasmas to adhere to host epithelial 
cells on mucosal surfaces, in the case of M. hominis the urogenital tract, is an essential stage to establish suc-
cessful colonisation. Several mycoplasmas, such as M. pneumoniae and M. genitalium, have adhesin proteins 
associated with adhesion concentrated at specific tip structures [45]. In comparison, M. hominis, along with 
other mycoplasma species, lack this attachment organelle. Many surface antigens have been identified in M. 
hominis and some of these play a role in cyto-adherence as shown by monoclonal antibody inhibition assays [17] 
[20]. 
Vaa has been shown to be involved in the adherence of M. hominis to host cells. Vaa was identified as a po-
tential adhesion of M. hominis using monoclonal antibody inhibition, with the masking of Vaa (P50) showing 
prominent difference in the ability of M. hominis to adhere to HeLa cells [17] [20]. The role of Vaa as an adhesin 
of M. hominis was further investigated by determining which region of a category 1 Vaa protein was involved in 
adhesion to host cells [46]. Adhesion to glutaraldehyde-fixed HeLa cells with module III, modules III + IV, 
modules III + V (truncated proteins expressed in Escherichia coli) indicated the adherent property was distrib-
uted over the entire molecule, not localised to a specific region. However, adherence was increased when exam-
ining multiple modules [20] [46]. 
This is further supported by the markedly reduced cyto-adherence of truncated Vaa proteins to cultured HeLa 
cells compared to the complete protein. Phase variation of the Vaa gene in a clonal lineage of M. hominis 1620 
results in a mutation in the N-terminal of the gene and the production of a truncated form of the Vaa protein 
(Vaa−). This Vaa− variant showed a >70% reduction in adherence to HeLa cells compared to a variant expressing 
the full length protein [22]. Examination of the membrane protein profiles of both the Vaa− and Vaa+ variants 
revealed that the only detectable difference was the presence or absence of the Vaa protein indicating that the 
difference in adhesion was directly attributed to the expression of this protein [22]. Low residual adhesion of the 
Vaa− variant could be attributed to non-specific interactions between M. hominis and HeLa cells or from addi-
tional, unidentified adhesins [22]. However, adherence of a recombinant peptide containing the N-terminal re-
gion of category 1 Vaa has been demonstrated indicating that even the Vaa− variant may retain the ability to ad-
here through the N-terminal region of the peptide [46].  
6. Conclusion 
The ability for M. hominis to adhere to host cells is a crucial step towards colonisation of a host. The Vaa antigen 
is a major adhesin of M. hominis and displays pronounced mutational variation in size as well as sequence and 
antigenic variation. To date the only mechanism described of altering Vaa expression relates to a truncation 
mechanism mediated by a poly-A (alanine-encoding) tract 161 bp down-stream of the ATG start codon, rather 
than a recombinase-mediated gene rearrangement such as described for phase variation in other mycoplasmas. 
Vaa truncation does, however, directly relate to the ability of M. hominis to adhere to host cells. Vaa displays a 
mosaic gene structure formed from interchangeable cassette sequences. Recombination of these cassette se-
quences results in different gene types thereby generating and maintaining functional diversity in M. hominis. 
Furthermore, methods of sequencing and characterising these distinct groups should be employed to determine if 
different Vaa modules are associated with isolation from different patient groups or sample sites. A method that 
begins the process of investigating differences between commensal populations and those that are associated 
with disease is overdue for this organism. 
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Supplementary Appendix  
Materials and Methods 
Isolates, Growth Media, and DNA 
M. hominis isolates UK2012a, Uk2004a, UK2006, UK2008a, UK2012b, UK2012c, UK2004b, UK1993, 
UK2008b, UK2004c, UK1989 and UK2012d were submitted to Public Health England, U.K. for clinical diag-
nostic purposes. M. hominis isolates were grown in Mycoplasma Liquid Medium (Mycoplasma Experience, 
UK). Bacterial DNA from a 500 µl 48 hour culture was released by boiling lysis (95˚C for 10 minutes) follow-
ing centrifugation at 13,000 x g for 10 minutes, removal of all MLM, and resuspended in 50 µl sterile water. 
PCR Amplification 
PCR was performed using the published primers of Zhang and Wise (1996) and the PCR conditions were per-
formed as detailed by Boesen et al. (1998) [23] [32]. All the oligonucleotide primers were synthesised by invi-
trogenTM (UK) and the sequences of these primers are detailed in Table 1. All PCR amplifications were per-
formed in a DNA thermocycler (Techne Prime) in a volume of 50 µl containing: 1 x GoTaq® Flexi Buffer 
(Promega), 1.5 mM MgCl2, 0.2 mM deoxynucleoside triphosphates, 0.5 pM of each primer, 1.56 units of Go-
Taq® DNA Polymerase (Promega), and 2.5 µl DNA. The PCR products were analysed on 1.5% agarose gels 
with ethidium bromide visualisation. All PCR reactions were repeated twice. 
 
Table 1. Primer sequences used for amplification of the vaa open-reading frame.                    
Primer name Sequence Target Reference 
VaaF1 5’-CCCCGGAGATTATTAAGTCT-3’ Flank the entire open-reading  
frame encoded by the vaa gene 
Zhang and Wise  
(1996) [23] VaaR1 5’-GTGCCCATTAGTAGCACTAT-3’ 
DNA Sequencing 
PCR amplicons were purified using a Qiagen Mini Prep kit (Qiagen) as per manufacturer’s instructions and se-
quenced using the amplification primers, as performed by MWG Eurofins (Germany). 
Sequence Analysis 
Open-reading frame amino acid sequence was identified using Expasy translation tool (mycoplasma setting; 
web.expasy.org/translate/). Sequences were aligned with CLUSTAL omega (www.ebi.ac.uk/tools/msa/clustalo/) 
and deduced amino acid sequences were compared to published Vaa amino acid sequences. Module composition 
was based on published sequence data by Boesen et al. (1998) [32]. 

